935 related articles for article (PubMed ID: 15237006)
1. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
2. Current treatment of dysfunctional uterine bleeding.
Bongers MY; Mol BW; Brölmann HA
Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
[TBL] [Abstract][Full Text] [Related]
3. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
5. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
6. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
7. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
8. The impact of alternative treatment for abnormal uterine bleeding on hysterectomy rates in a tertiary referral center.
van Dongen H; van de Merwe AG; de Kroon CD; Jansen FW
J Minim Invasive Gynecol; 2009; 16(1):47-51. PubMed ID: 18990612
[TBL] [Abstract][Full Text] [Related]
9. [Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Yazbeck C; Omnes S; Vacher-Lavenu MC; Madelenat P
Gynecol Obstet Fertil; 2006 Oct; 34(10):906-13. PubMed ID: 16987684
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
Hawe J; Abbott J; Hunter D; Phillips G; Garry R
BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
12. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
15. Conducting randomized, controlled trials. Experience with the dysfunctional uterine bleeding intervention trial.
Rolnick SJ; Flores SK; Fowler SE; Derman R; Davidson B
J Reprod Med; 2001 Jan; 46(1):1-5, discussion 5-6. PubMed ID: 11209624
[TBL] [Abstract][Full Text] [Related]
16. Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life.
Bongers MY; Bourdrez P; Heintz AP; Brölmann HA; Mol BW
Fertil Steril; 2005 Mar; 83(3):724-34. PubMed ID: 15749505
[TBL] [Abstract][Full Text] [Related]
17. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up of endometrial ablation.
Fürst SN; Philipsen T; Joergensen JC
Acta Obstet Gynecol Scand; 2007; 86(3):334-8. PubMed ID: 17364309
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding.
Kucuk M; Okman TK
Fertil Steril; 2005 Jan; 83(1):189-94. PubMed ID: 15652906
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
